Healthcare revenue cycle leaders are headed into uncharted territory under the new administration, but there are a few signs that can be useful in charting a path forward.
The first Trump administration featured a range of reductions in restrictions and loosening of prior regulations. For the healthcare revenue cycle, it’s impossible to know exactly what’s coming this term, but